In this episode, we sit down with one of the most influential figures in government today: Federal Trade Commission Chair Lina Khan. As the youngest FTC chair to ever be appointed, during her tenure the FTC has pushed to ban non-compete agreements, filed lawsuits against healthcare companies engaging in anti-competitive practices, and strengthened the Health Breach Notification Rule (HBNR) to protect sensitive health data.
We cover:
- The FTC's role in healthcare and how it compares to other sectors
- The impact of consolidation and vertical integration in the healthcare industry
- The agency's efforts to combat rising drug prices, including the recent actions against major PBMs
- The controversial "Orange Book" patent challenges and their implications for drug innovation
- The nationwide ban on non-compete agreements and its potential effects on doctors
- Chair Khan's vision for the future of competition law and its application to healthcare
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
